Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amgen inc. crawled time : 12:30 save search
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
Published: 2023-10-06 (Crawled : 12:30) - prnewswire.com
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.62%
H: 1.06%
C: 0.25%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.73%
H: 2.07%
C: 1.64%
acquisition therapeutics
HP Inc. Names David Meline to Board of Directors
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
ABBNY | News | $48.37 4.05% 180K
|
n/a
|
| O: -0.99%
H: 0.5%
C: -0.17%
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: -1.68%
H: 0.02%
C: 0.02%
HPQ | $27.81 0.69% 0.0% 4.8M
|
Electronic Technology
|
| O: 0.0%
H: 0.67%
C: -0.96%
GM | News 1 d | $42.37 -0.17% 0.0% 15M
|
Consumer Durables
|
| O: -0.87%
H: 1.6%
C: -0.61%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: -0.44%
H: 0.68%
C: -1.08%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation
Published: 2022-01-13 (Crawled : 12:30) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -5.11%
H: 1.25%
C: -4.2%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
bbp-398 lumakras solid tumors potential collaboration
Thyroid Gland Disorder Treatment Market Records a CAGR of 4.63% by 2025|35% of Growth to Originate from North America |17000+ Technavio Reports
Published: 2021-12-14 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.37%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.4%
H: 4.78%
C: 2.07%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.77%
H: 0.6%
C: 0.23%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.22%
H: 1.65%
C: 1.15%
treatment order growth
Bristol Myers Squibb’s Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -1.18%
H: 1.16%
C: 0.49%
psoriasis food treatment europe application drug plague
Entera Bio Ltd Announces Operating and Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Published: 2021-03-18 (Crawled : 12:30) - globenewswire.com
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: -7.75%
H: 2.66%
C: -10.28%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -1.54%
H: 2.76%
C: 1.63%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.